Encompass Health Co. (NYSE:EHC – Get Rating) – Analysts at William Blair decreased their Q3 2022 EPS estimates for Encompass Health in a research note issued to investors on Tuesday, August 2nd. William Blair analyst M. Larew now expects that the company will post earnings of $0.74 per share for the quarter, down from their previous forecast of $0.94. The consensus estimate for Encompass Health’s current full-year earnings is $3.02 per share. William Blair also issued estimates for Encompass Health’s Q4 2022 earnings at $0.86 EPS, Q4 2023 earnings at $1.10 EPS and FY2023 earnings at $4.01 EPS.
Encompass Health (NYSE:EHC – Get Rating) last posted its earnings results on Monday, August 1st. The company reported $0.89 EPS for the quarter, missing the consensus estimate of $0.97 by ($0.08). The business had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.34 billion. Encompass Health had a return on equity of 16.20% and a net margin of 6.22%. The business’s revenue was up 3.3% on a year-over-year basis. During the same period in the prior year, the firm earned $1.17 earnings per share.
Encompass Health Stock Performance
EHC stock opened at $52.91 on Friday. The company has a quick ratio of 1.26, a current ratio of 1.24 and a debt-to-equity ratio of 1.29. The company has a market capitalization of $5.28 billion, a price-to-earnings ratio of 16.17, a P/E/G ratio of 2.41 and a beta of 0.91. Encompass Health has a 12 month low of $44.33 and a 12 month high of $81.45. The firm has a 50 day moving average of $54.14 and a two-hundred day moving average of $62.81.
Institutional Trading of Encompass Health
A number of hedge funds have recently bought and sold shares of the stock. Meeder Asset Management Inc. acquired a new position in shares of Encompass Health in the 1st quarter valued at $33,000. Worth Asset Management LLC acquired a new position in shares of Encompass Health in the 1st quarter valued at $35,000. Covestor Ltd acquired a new position in shares of Encompass Health in the 4th quarter valued at $38,000. Allworth Financial LP raised its stake in shares of Encompass Health by 83.1% in the 1st quarter. Allworth Financial LP now owns 630 shares of the company’s stock valued at $45,000 after buying an additional 286 shares in the last quarter. Finally, Rather & Kittrell Inc. acquired a new position in shares of Encompass Health in the 4th quarter valued at $49,000. 91.70% of the stock is owned by institutional investors.
Encompass Health Cuts Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Monday, October 3rd will be issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date is Friday, September 30th. Encompass Health’s dividend payout ratio (DPR) is presently 34.25%.
About Encompass Health
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
- Get a free copy of the StockNews.com research report on Encompass Health (EHC)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.